how many people take glp-1 Poll: 1 in 8 Adults Say They Are Currently Taking a Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford Ozempic Statistics: GLP-1 Weight Loss

Invest in a large pharmaceutical company that has their sights set on the obesity market with drugs in development

monotherapies [118, 119]

Additional potential benefits include berberine's reported effects on lipid profiles, with some studies suggesting reductions in LDL cholesterol and triglycerides, though evidence is of low-to-moderate certainty with heterogeneous results

J Pharmacol Exp Ther (2006) 317:110613

Drugs like Orforglipron and amycretin are advancing through clinical trials

Our approach is built around maintaining product integrity, ensuring traceability, and supporting research workflows that depend on consistent materials over time